Webinar
Mitigating risk and complexity in Cell & Gene Therapy trials with IRT
calendar

February 11, 2025

Calendar
clock

11:00am - 12:00pm

(GMT-05:00)

Register

View all IQVIA events

Cell and Gene Therapies (CGT) promise critical and transformative benefits to patients. Even with record funding and new launches in this sector, trial and patient journey complexities pose significant barriers to the success and sustainability of these treatments. CGT pioneers require supply chain partnerships that mitigate trial risk and complexity and provide a consultative approach to protocol execution. Let’s explore how to succeed by optimizing pre-trial and pre-screening activities and reducing trial cost and risk with your IRT solution.

Key Takeaways:

  • How to leverage your technology provider as a key consultant in technology and process support for protocol execution.
  • Ways to optimize pre-trial and pre-screening activities through flexibility and strict control of process in IRT.
  • How to reduce cost and risk with advanced drug supply technology.

Speaker:

Cara Woodruff
Director, Product Management, IQVIA IRT

Related solutions

Contact Us